Related Experiment Video
Updated: Oct 20, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Effectiveness of different therapy protocols in preemies with intestinal hypomotility
Vesna Hajdarpasic1, Maja Raicevic2, Marija Lukac3
1Neonatal Intensive Care Unit, Institute of Neonatology, Belgrade, Serbia - hajderpasic@yahoo.com.
Background:
Intestinal hypomotility delays achievement of full enteral feeds and normalization of stooling patterns in preemies. We hypothesized that introduction of prokinetic drug in addition to enemas would improve intestinal motility. Primary outcome: time needed to achieve full enteral feeds and normal stooling pattern. Secondary outcome: day when start of minimal enteral feeding was feasible, necrotizing enterocolitis incidence, length of hospitalization and whether daily meconium evacuation is more effective than evacuation in presence of clinical symptoms only.
Methods:
A randomized controlled trial was conducted from December 1st, 2015 until December 1st, 2016 in level III neonatal unit on 67 preterm infants ≤32 gestational weeks and intestinal hypomotility. Infants were allocated to: group 1, treated with saline enemas twice daily until normal stooling pattern was achieved; and group 2, treated with erythromycin and enemas. Infants with intestinal hypomotility, hospitalized from December 1st, 2014 to December 1st, 2015, were assigned to group 3, and were treated with enemas only when symptoms of abdominal distension or absence of stool for 48 hours were observed.
Results:
Total of 127 neonates was included in this study; 33 were assigned to group 1, 34 to group 2, and 60 to group 3. There was no significant difference in number of days needed to reach full enteral feeds: 25 vs. 26 days and normal stooling pattern: 18 vs. 15 between groups 1 and 2. Time needed to achieve full enteral feeds and normal stooling pattern in groups 1 and 2 were significantly shorter when compared to group 3. No difference in length of hospitalization between the groups was observed.
Conclusions:
Erythromycin did not improve the patient outcome, although therapy protocol in group 1 and group 2 were more effective than therapy used in patients in group 3.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
06:01Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
Related Concept Videos
Gastrointestinal Motility Disorders
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Constipation-Predominant IBS